Omega Healthcare (OHI) Fundamental Analysis: Revenue, Earnings & Valuation

5.20 / 10

Netural

Fundamental analysis rates OHI at 5.2/10, reflecting average quality. Strengths include cash‑to‑market, PB‑ROE, robust YoY revenue (13.2%) and equity growth (14.2%). Weaknesses appear in asset‑to‑market and profit‑to‑market ratios, keeping the overall score modest.

Analysis Checks(8/10)

Revenue-MV

Value-1.33

Score2/3

Weight12.55%

1M Return4.85%

Net assets per share (growth rate compared to beginning of year %)

Value7.87

Score3/3

Weight6.77%

1M Return3.58%

Total operating revenue (YoY growth rate %)

Value13.19

Score3/3

Weight8.97%

1M Return4.55%

Profit-MV

Value0.89

Score1/3

Weight5.39%

1M Return3.01%

Net income-Revenue

Value1.39

Score2/3

Weight9.44%

1M Return4.21%

PB-ROE

Value0.18

Score3/3

Weight17.05%

1M Return6.23%

Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)

Value14.21

Score3/3

Weight6.08%

1M Return3.39%

Cash-UP

Value-0.11

Score3/3

Weight18.00%

1M Return6.78%

Asset-MV

Value0.10

Score1/3

Weight4.67%

1M Return2.35%

Cash-MV

Value-0.19

Score2/3

Weight11.08%

1M Return4.72%

Is OHI undervalued or overvalued?

OHI scores 5.20/10 on fundamentals and holds a Fair valuation at present. Backed by its 11.60% ROE, 51.21% net margin, 22.40 P/E ratio, 2.43 P/B ratio, and 24.84% earnings growth, these metrics solidify its Netural investment rating.